Microbot Medical Inc. to Present at the 29th Annual ROTH Growth Conference
March 13 2017 - 7:00AM
Microbot Medical Inc. (Nasdaq:MBOT), a medical device company
specializing in the design and development of transformational
micro-robotic medical technologies, is scheduled to present at the
29th Annual ROTH Conference on Wednesday, March 15, 2017 at 7:00 am
PT (10:00 am ET) at The Ritz Carlton in Dana Point, California.
Attendance at the conference is by invitation only.
A live webcast and subsequent archived replay of
the Company’s presentation may be accessed via the ‘Investors’
section, under ‘Presentations and Resources’ of the Company’s
website at www.microbotmedical.com.
About Microbot Medical, Inc.
Microbot, which was founded in 2010 and commenced
operations in 2011, became a NASDAQ listed company on November 28,
2016. The Company specializes in transformational micro-robotic
medical technologies leveraging the natural and artificial lumens
within the human body. Microbot’s current platforms, ViRob and
TipCAT, are comprised of two highly advanced micro-robotic
technologies, from which the Company is currently developing its
first two product candidates: the Self Cleaning Shunt, or SCS, for
the treatment of hydrocephalus and Normal Pressure Hydrocephalus,
or NPH; and a self-propelling, semi-disposable endoscope that is
being developed initially for use in colonoscopy procedures.
Further information about Microbot Medical is available at
http://www.microbotmedical.com.
The ViRob technology is a revolutionary autonomous
crawling micro-robot which can be controlled remotely or within the
body. Its miniature dimensions allow it to navigate and crawl
in different spaces within the human body, including blood vessels,
the digestive tract and the respiratory system. Its unique
structure gives it the ability to move in tight spaces and curved
passages as well as the ability to remain within the human body for
prolonged time. To learn more about ViRob please visit
http://www.microbotmedical.com/technology/virob/.
TipCAT is a transformational self-propelled,
flexible, and semi-disposable endoscope providing see & treat
capabilities within tubular lumens in the human body such as the
colon, blood vessels, and the urinary tract. Its locomotion
mechanism is perfectly suitable to navigate and crawl through
natural & artificial tubular lumens, applying the minimal
necessary pressure to achieve the adequate friction required for
gentle, fast, and safe advancement within the human body. To
learn more about TipCAT visit
http://www.microbotmedical.com/technology/tipcat/.
Investor Contacts:
EVC Group
Michael Polyviou//Doug Sherk - Investors
mpolyviou@evcgroup.com/dsherk@evcgroup.com
646-445-4800
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Sep 2023 to Sep 2024